Quiz: What’s one advantage the president has that the market does not?

Answer: He can get a doctor’s note telling you everything is wonderful. 

But investors? They’re left on their own, left trying to forecast when a stimulus bill will land, left watching every vaccine trial to spot a winner, left waiting up at night for earnings reports, and left tracking technical indicators for clues about what’s churning underneath the surface. 

Fortunately, investors do, however, have experts who can guide them. Helping us get through this messy, mucky October are Real Money and Real Money Pro writers Jim Cramer, Paul Price, Maleeha Bengali, Alex Frew McMillan, and Jim Collins.

Jim Cramer: Let’s Beat Covid-19

Cramer lays out what is happening right now to get the pandemic under control and what it will look like not that long from now — even before a vaccine is available.

Here’s the tests and therapies that Cramer contends will change the channel on the Covid outlook.

Price: Give Stocks a Second Chance 

Few stocks go up in straight-line moves. Instead, writes Price, most tend to spurt higher, tail off, then rise again. While the interim selloffs often shake out traders who mainly trade on momentum, plus those who fail to understand the companies’ true worth, there’s still opportunity awaiting for those willing to give second chances.

Source Article